As a healthcare provider, I want to add some clinical context to this discussion on Prior auth denied for the 3rd time -.
Building on what Dr.PulmRoch said — the evidence base here is well-established. The key publications to reference are from the SELECT program[1].
Key clinical points:
- Efficacy is dose-dependent and typically requires 4-5 weeks to reach steady state
- Side effect profile is predictable and usually manageable with standard protocols
- Monitoring should include baseline labs and follow-up at 3-month intervals
- Patient education significantly improves outcomes and adherence
Standard disclaimer: this is educational, not individualized medical advice.
[1] See thread title for relevant study identification.
Reading this thread on Prior auth denied for the hits close to home. Night shift nurse — I started at 279 lbs and felt like I would tried everything.
15 months on tirz and I am a different person. Not just the 54 lbs lost — my energy, my mood, my relationship with food. All transformed.
If you are on the fence about Prior auth denied — take the leap. It was the best health decision I have ever made. ❤️
Janoshik Analytical — Independent Testing
Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.
Verify Your PeptidesGenomicsKate — that is really helpful context on Prior auth denied for the. Follow-up question: what labs did your doctor order to monitor this?
I am in a similar situation (just started) and trying to set realistic expectations.
To answer BrianDallas92's question specifically:
From a clinical standpoint, Prior auth denied for the 3rd is an area where we have good evidence.
The short answer: baseline labs + quarterly monitoring is the standard of care.
The longer answer involves understanding the mechanism of action at the receptor level, which I am happy to elaborate on if helpful.